- Home
- Past Conferences
- Antiviral
Antiviral
28 Sep - 01 Oct 2014
El Jadida, Morocco
-
Kenneth Powell
ReViral Ltd.
-
Raymond F. Schinazi
Emory University School of Medicine
Early Bird - Expired • Talk Submission - Expired • Poster Submission - Expired • Registration & Payment Deadline - Expired
Synopsis
*Thank you to our media partners; the European Society for Virology and the Journal of General Virology.*
The four day conference will focus on Antiviral Research with a combination of plenary lectures, invited lectures and contributing talks which will be selected from the open abstract submissions (submissions can be uploaded upon registration). A broad range of topics will be covered focusing on the latest clinical practice, as well as the discovery and development of antiviral agents for the treatment and cure of various infectious agents.
Key Sessions
- HIV (Treatment)
- HIV (Eradication)
- HBV
- HCV
- Respiratory Viruses
- Vector Borne Viruses
- Norovirus & Emerging Viruses
- Herpes Viruses
- Global Pandemics
Our speakers will discuss the latest developments and cutting edge research and look to address the question “What is next for the industry?” The purpose of this conference is to provide a platform for discussion, collaboration and free exchange of ideas, allowing all participants to present their work either as a talk or in poster form.
Educational Objectives
The conference will address the following learning objectives:
- Update participants on the overall progress in antiviral research
- Inform clinicians of their choices in patient treatments with existing licenced antiviral therapies
- Describe the pipeline of new compounds in development and their likely impact on patient treatments
- Enhance the understanding of participants of the development of resistance to antiviral drugs and the importance of treatment selection and adherence to the correct dosing regimens
- Evaluate the unmet needs for antiviral drugs to guide both academic and industry participants in their choice of research topics
- Help participants foresee the impact of the latest discoveries in virology on the search for new therapies.
Target Audience
This conference will look to bridge the gap between clinical practise, industry and academia and will actively encourage the participation MDs, clinicians, nurses, clinical lab directors, clinical service planners, academic researchers and pharmaceutical industry representatives.
Confirmed Plenary Speakers
Daria Hazuda
Merck
Mario Stevenson
University of Miami Health System
Michael Manns
Hannover Medical School
Guey Chuen (Oscar) Perng
National Cheng Kung University
Brent Korba
Georgetown University
Helga Rubsamen-Schaeff
AiCuris
Yves Benhamou
Hôpital Pitié-Salpêtrière
Confirmed Invited Speakers
Baek Kim
Emory University
Carol Brosgart
Viral Hepatitis Action Coalition, CDC Foundation
Leonid Margolis
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Massimo Levrero
Sapienza Universita' di Roma
Osvaldo (Lalo) Flores
Novira Therapeutics
Tarik Asselah
University Paris Diderot
Confirmed Speakers
Chairs
Kenneth Powell
Chairman, ReViral Ltd.
Raymond F. Schinazi
Professor of Pediatrics and Director, Emory University School of Medicine
Plenary Speakers
Daria Hazuda
Vice President, Merck
Mario Stevenson
Chief of Infectious Diseases, University of Miami Miller School of Medicine
Oscar Perng
Associate Professor, National Cheng Kung University
Helga Rübsamen-Schaeff
CEO, AiCuris GmbH & Co. KG
Brent Korba
Professor, Georgetown University Medical Center
Invited Speakers
Baek Kim
Director of Drug Discovery, Emory University
Massimo Levrero
Professor of Medicine, Sapienza University of Rome
Lalo Flores
President & CSO, Novira Therapeutics
Leonid Margolis
Section Chief, NIH
Tariq Rana
Professor and V/C, UCSD School of Medicine
Programme
Sunday 28th September 2014 |
|
|
20:00 |
Group Dinner (Meeting Point: Market Place Buffet Restaurant) |
Monday 29th September 2014 |
|||||
|
HIV (Eradication/Treatment) I |
|||||
|
08:20 – 08:30 |
Opening Comments |
||||
|
08:30 – 09:00 |
Tariq Rana |
TARGETING VIF REGULATORY AXIS: DEVELOPING NEW AIDS THERAPIES |
|||
|
09:00 – 09:45 |
Mario Stevenson |
|
|||
|
09:45 – 10:00 |
Carole Devaux |
IDENTIFICATION OF A SMALL HIV-1 NEUTRALIZING ANTIBODY FRAGMENT MIMICKING THE CXCR4 AND CCR5 SURFACE IN A VIREMIC CONTROLLER |
|||
|
10:00 – 10:30 |
Refreshments |
||||
|
HIV (Eradication/Treatment) II |
|||||
|
10:30 – 11:15 |
Daria Hazuda |
HIV LATENCY DRUG DISCOVERY: OPTIMIZING DRUGS TO INDUCE LATENT HIV EXPRESSION |
|||
|
11:15 – 11:45 |
Baek Kim |
Vpx CONTRIBUTES TO INSENSITIVITY OF SIV to NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS |
|||
|
11:45 – 12:15 |
Panel Discussion |
||||
|
12:15 – 17:00 |
Group Lunch in Olives Buffet Restaurant & Free Time |
||||
|
14:00 – 17:00 |
Group Tour to El Jadida (Meeting Point: Hotel Lobby) |
||||
|
HBV & HCV |
|||||
|
17:00 – 17:30 |
Massimo Levrero |
CAN WE ELIMINATE OR SILENCE THE CCCDNA AND CURE CHB? |
|||
|
17:30 – 18:00 |
Lalo Flores |
CORE INHIBITORS: AN ATTRACTIVE NOVEL CLASS OF HBV DRUGS THAT PROMISES TO INCREASE FUNCTIONAL CURES RATES |
|||
|
18:00 –18:30 |
Refreshments |
||||
|
18:30 – 19:15 |
Michael P. Manns |
HEPATITIS C: FROM VIRUS DISCOVERY TO CURE |
|||
|
19:15 – 19:45 |
Tarik Asselah |
INTERFERON-FREE TREATMENT WITH DIRECT ACTING ANTIVIRALS FOR HEPATITIS C: PERSPECTIVES FOR HCV ERADICATION |
|||
|
19:45 – 20:15 |
Panel Discussion |
||||
|
20:15 |
Group Dinner (Market Place Buffet Restaurant) |
||||
Tuesday 30th September 2014 |
|||||
|
Herpesviruses |
|||||
|
08:30 – 09:15 |
Helga Rübsamen-Schaeff |
NOVEL THERAPEUTIC APPROACHES AGAINST HERPESVIRUSES |
|||
|
09:15 – 09:45 |
Leonid Margolis |
HERPESVIRUSES: HIV EVIL ASSOCIATES |
|||
|
09:45 – 10:15 |
Panel Discussion |
||||
|
10:15 – 10:45 |
Refreshments |
||||
|
Vector Borne, Norovirus & Emerging Viruses |
|||||
|
10:45 – 11:30 |
Brent Korba |
NOROVIRUS CONTAINS DIVERSE AND UNIQUE ANTIVIRAL TARGETS |
|||
|
11:30 – 12:15
|
Oscar Perng |
|
|||
|
12:15 – 12:45 |
Panel Discussion |
||||
|
12:45 – 17:00 |
Group Lunch in Olives Buffet Restaurant & Free Time |
||||
|
Respiratory Viruses |
|||||
|
17:00 – 17:45 |
Kenneth Powell |
DEVELOPMENT OF NOVEL COMPOUNDS TO TREAT RSV INFECTION |
|||
|
17:45 – 18:00 |
James Mahony |
CREATION OF NOVEL ANTIVIRALS FOR RESPIRATORY VIRUSES USING SINGLE DOMAIN ANTIBODIES (mFc) AND PEPTIDE INHIBITORS AS THERAPEUTIC FUSION PROTEINS |
|||
|
18:00 – 18:30 |
Panel Discussion |
||||
|
18:30 – 19:00 |
Refreshments |
||||
|
Special Plenary |
|||||
|
19:00 – 19:45 |
Raymond F. Schinazi |
Curing HCV: The best is yet to come |
|||
|
20:00 – 23:00 |
Gala Night & Group Photo in Morjana Restaurant |
||||
Supported by
Venue & Location
Mazagan Beach Resort
Relax in the warm Moroccan sun at the Mazagan Beach Resort, a truly beautiful hotel situated along the coast with stunning panoramic views across the Atlantic Ocean. The resort combines traditional Moroccan culture with a modern twist creating an unforgettable conference experience for all.
The resort covers over 250 hectares offering an amazing array of activities and entertainment for delegates to choose from during their free time at the conference.
Throughout your stay delegates will enjoy a buffet feast for breakfast, lunch and dinner. During each meal delegates are entitled to selected beverages and 1 glass of house wine during dinner. The themed Moroccan Gala Night takes place on the third evening of the conference with a mouth-watering feast of local cuisine, an open bar and live performing band. We welcome all delegates and their accompanying persons to the Gala Night – a truly fun filled night not to be missed!
Hotel Facilities
- Beach
- Resort Swimming Pool
- Fitness Centre
- Wellness Spa
- Complimentary WI-FI in guestrooms and conference areas
General Information
Venue Rating
★ ★ ★ ★ ★
Currency
US Dollar (USD)
Address
Nearest Airport
Mohammed V International Airport (CMN)
Location
Morocco has over 2000miles of unspoilt sandy beaches, more than 300 days of sunshine per year and with its warm, friendly, hospitable people and delicious cuisine Morocco creates a perfect and unique location to hold a conference! Morocco is an ethnically diverse country with a rich culture and history. The region offers something for everyone, whether you like exploring the old winding medinas of its cities and towns, strolling along the stunning beaches, hiking the temperate peaks of the Rif mountain range or tasting some of the countries diversified cuisine.
Not far from the Mazagan Beach Resort is the Portuguese City of Mazagan, now known as El Jadida. It is one of the early settlements of the Portuguese explorers in West Africa on the route to India - it is an outstanding example of the interchange of influences between European and Moroccan cultures, well reflected in architecture, technology, and town planning. Popular sites include; The Municipal Theater of El Jadida, The Portuguese Cistern, The Canons and the Fortress and The Old Port. El Jadida is definitely a city worth visiting during your stay.
Gallery
View on FlickrIf you are interested in this meeting but not yet ready to register, you can sign up for updates here and our team will keep you updated regarding deadline reminders and grant opportunities relating to this meeting only.
Silver Sponsors
Media Partners
If you're interested in sponsoring this conference please contact us.
Conference Manager
Laura Trundle
Need some help? Chat to the Fusion team today
As a family run business, our dedication runs deep. We’re committed to each other and, even more so, to every attendee’s experience, delivering a level of care and passion that’s truly unmatched.
